XTPL DEBUTES ON THE WARSAW STOCK EXCHANGE (GPW)

Today, our portfolio company XTPL has been listed at the Warsaw Stock for the first time, making a first debut of 2019.

“Debut on the GPW is another stage in the development of our company, we are building a company with global ambitions. The cost-effective, simple and therefore scalable XTPL technology can completely change the way certain industries produces advanced electronics “- said Filip Granek, president and co-founder of XTPL after his debut.

The transition from the NewConnect market to the main trading floor of the GPW is aimed at attracting new institutional investors, both international and domestic, investing in groundbreaking innovations on a global scale. The next step will be to start the dual – listing at the Frankfurt Open Market.

At the same time, XTPL develops structures and intensifies operations in the USA, where it has just launched its branch in Silicon Valley. XTPL Inc. is to support key IP security processes and implementations in cooperation with industrial tycoons on the US market.

XTPL – congratulations and we wish you continued success!

GENOMTEC AWARDED IN THE COMPETITION POLISH PRODUCT OF THE FUTURE

GENOMTEC doesn’t slow down … We’ve just announced about acquiring nearly 9 million for further development and commercialization of technology in the Fast Track program. This time, we’re pleased to inform you about the prize and distinction that GENOMTEC received for the Genomtec ID solution, as part of the prestigious competition organized by PARP and NCBIR – Polish Product of the Future. In the Polish Product of the Future (Polski Produkt Przyszłości) competition, the most innovative Polish products and technologies are awarded. Genomtec received a distinction in the category: the future product of a joint projects (university and entrepreneur) and a special prize for a product created by a young entrepreneur. The awards were received by Genomtec CEO – Miron Tokarski. “Genomtec ID is a molecular biology laboratory in your pocket. It helps detect viruses in record time – less than 20 minutes. The technology can be used in diagnostics of people and animals. Its implementation will reduce the phenomenon of antibiotic resistance, reduce the incidence of side effects of drugs, speed up the treatment process and reduce the cost of treatment. ” Congratulations and we keep our fingers crossed for the fast commercialization! It’s a product that can help every one of us! 👏

GENOMTEC ON THE FAST TRACK

GENOMTEC received a positive evaluation of the National Center for Research and Development (NCBR) as part of the “Fast Track” competition. The company will receive nearly PLN 9 million in subsidies for further development of technology and product. Company develop Genomtec ID – handy, innovative diagnostic device based on the amplification and detection of specific DNA and RNA fragments – the “gold standard” of molecular diagnostics. This technology has a number of implementation possibilities in many areas of medicine, including the so-called liquid biopsy, immunological or biochemical tests.

The grant comes from the European Funds under the Intelligent Development Operational Program, thanks to which the National Center for Research and Development supports innovative solutions for micro, small and medium enterprises.

“With competitions such as the Fast Track, innovative solutions of start-ups like us are able to get a second wind” says Miron Tokarski, CEO of Genomtec.

Congratulations to the Genomtec team. We keep our fingers crossed for success!

XTPL GROWS STRONGER

XTPL technology is unique. It works and can be widely used. The company has a great opportunity to become the main provider of advanced solutions for several serious American or Asian companies. This will mean that XTPL has big business within its reach, really big”, said Dr Hendrik Leber, managing director of Acatis Investment, which controls more than 7% of XTPL shares.” The German Investor has long believed in the potential of XTPL and supported the development of innovative technologies with its investments.

Filip Granek, co-founder and CEO of XTPL, adds:

We’re entering the hottest period of our growth. We have chosen the key application areas for nanoprinting, which at this stage we believe to be optimal in terms of the relation between inputs and effects. They include, for example, open defects repair, semiconductors and smart glass markets – sectors that are extremely absorbent when it comes to innovation. In these areas, our additive technology for precise deposition of conductive structures can make an absolute breakthrough”🚀

XTPL will soon make its debut on the regulated market of the Warsaw Stock Exchange. The prospectus of the nanotechnology company has just been approved by the Polish Financial Supervision Authority. The change of the quotation system will open access to a wider base of institutional investors and will enable the start of efforts for a dual listing of the company on one of the Western European exchanges – informs a nanotechnology company on its website. Speaking in a football language, XTPL will advance to the top league and have the chance to play in international competitions. ”

XTPL’s interest is growing both at home and abroad. One example is the publication of Business Insider, which we highly recommend reading !!! ⬇

https://markets.businessinsider.com/news/stocks/xtpl-with-additional-capital-from-german-investors-sets-up-operating-structures-in-silicon-valley-1027884893

PKO BP IMPLEMENTS EMPLOBOT

Emplocity Founders – Arkadiusz Talun and Krzysztof Sobczak

2018 was a year of success for Emplocity. The company created a completely new product, started further R&D project on autonomous artificial intelligence, developed its structures and won numerous awards and challenges. All this means that today we do not talk about Emplocity as a startup, but about a full-fledged provider of Enterprise solutions, with which the largest brands such as mBank, Aviva and Santander cooperate. 2019 promises to be even better. Emplocity begins it with another success. The group of clients has expanded by PKO BP, the largest bank in Poland, which implements Emplobot – a recruitment bot created in Messenger. This is the next step of the bank in making digital transformation, part of which becomes now Emplocity. Congratulations to the entire Emplocity team and wish you continued success! We are happy that we can be part of this success.

To find out more click here.

QQN’S STOCK EXCHANGE DEBUT

We are pleased to inform you that on January 18, 2019, QuarticOn S.A. was first quoted on the NewConnect market.

QuarticOn is a technology company that creates IT applications operating in the SaaS model based on a computing cloud. The flagship products of the company are the engine of personalized recommendations for e-commerce along with the system for personalization of advertising creations addressed to the segment of medium-sized online stores (Segment Supreme) and a recommendation engine for video offered to large enterprises (Enterprise Segment). Since 2018, for both segments, QQN offer also a system for personalizing recommendations in e-mails.

QuarticOn S.A. is the 388th company listed on the NewConnect Market and the 2nd debut on this market in 2019.
Congratulations and we wish you further development and high quotations 🚀

Details related to the debut and more information about the Company can be found on the NewConnect official website. https://newconnect.pl/relacje-z-debiutow?ph_main_01_start=show&ph_main_01_cmn_id=16201&title=Pierwsze+notowanie+sp%C3%B3%C5%82ki+QUARTICON+S.A.+na+rynku+NewConnect

APS Ctrl+SKY SYSTEM INTEREST RAISED AFTER GATWICK DRONE DISASTER

48h standstill at Gatwick airport caused by sighting of a drone, began hot discussion in regards of airports safety from unmanned aircrafts. The question asked is to does the security system exists, which can prevent these incidents? The answer is Yes, and they are offered by our portfolio company – Advanced Protection System, which starts to implement the security of the system at Stavanger airport in Norway. The Norwegians saw the advantages of the Ctrl+Sky system and signed the contract at the end of last year. We hope that many other will follow Norwegian suite and APS will grow their wings to secure safe and on time flight. SkyNews during their poll on security from the drones didn’t give the ultimate answer if they do or don’t have the system, only that there is a plan to implement one and that the British Government ignored the problem for far too long. Will it be able to avoid Gatwick  drone disaster in the future? Or will it have to happen again?

Source: https://www.pb.pl/polacy-mogli-zlapac-drony-z-gatwick-950141

LEONARTO’S PORTFOLIO COMPANIES AGAIN AT THE TOP OF THE MIT ENTERPRISE FORUM PROGRAM

We are slowly getting used to the successes of our portfolio companies in leading acceleration programs. The success gained by Pregnabit in the 3rd and Genomtec in 4th edition of the MIT Enterprise Forum acceleration program wasn’t enough. The time has come for edition No5 and again our companies were at the top – Bioavlee and BIOTTS.
The winnings will give Bioavlee an amazing opportunity of trip to Boston to take part in a Bootcamp.
BIOTTS company for its distinction received Wroclaw Technology Park S.A vouchers.

To find out more use the link below

https://mamstartup.pl/akceleracja/14334/polskie-startupy-leca-do-bostonu-znamy-finalistow-5-edycji-programu-mit-enterprise-forum-poland?fbclid=IwAR2wQ-0ucrTq1iRp1o-2QO4cmdJ37yuI_ZGw_Ckwe23E21tTE5znTYHjges

XTPL ranked the best investment of 2018

End of the year is always the best time  to review the passing year. The website rentier.io created the ranking of investments which have been keenly invested by Polish people. The investments have been presented by the highest return of ROI in the last 12 months. We are happy to announce that the XTPL has been ranked the best (spolka portfelowa). This is a fantastic news, which make us proud and give us optimism for 2019!

Congratulations to XTPL and keep up the good work!

More about:

https://forsal.pl/artykuly/1388470,od-xtpl-po-idea-bank-ranking-najlepszych-i-najgorszych-inwestycji-2018-roku.html?fbclid=IwAR1K1mBUbf_NpvfaazsT5IxQuQvadkY–G9MP-mPWjvJztWeQYWnWZTZw3A

ROOMSAGE IN THE FINALS OF AI MASTERS PUBLICIS AWARDS

We are pleased to announce that Roomsage is among the five finalists of the prestigious AI Masters Publicis Awards. The competition is one of the initiatives related to the organization of the AI Masters conference, which will take place on January 24-25, 2019 in Berlin.

RoomSage is one of the world’s first advertising technology platforms for hotels and digital marketers, powered by ORA the most advanced Artificial Intelligence (AI) and Machine Learning (ML) algorithms co-developed with the leading American Ivy League university researchers.

On December 15, two companies that will take part in the grand finale will be announced.
On January 24, the AI Masters conference will host the award ceremony and the winner of the competition will receive, among others, a cash prize of 25,000 euros.

We keep our fingers crossed for winning!

BIOAVLEE SELLS FIRST QUANTICA 500 COLONY COUNTERS

At the end of November, Bioavlee, our portfolio company, received an order for eight pieces of Quantica 500 colony counters. The order was completed on the same day. This is the first sale of Quantica 500 devices implemented by Bioavlee.

Quantica 500 is a device created for a wide audience, enabling automatic counting of microorganism colonies in quantitative analyzes during microbiological tests. Quantica 500 is more efficient, faster and cheaper compared to competitive solutions. Thanks to an efficient algorithm, the Quantica 500 correctly sums up even merged colonies. This feature gives the Bioavlee device a significant advantage over existing standard solutions, having difficulties in separating this type of colonies.

The Company is in talks with foreign distributors regarding the sale of Quantica 500, among others in France, Great Britain, Germany, Croatia, Spain and Turkey. At the beginning of next year, Bioavlee will provide foreign distributors with a series of test equipment.

Congratulations on the first sale!

BIOCELTIX AMONG THE 5 FINALISTS OF THE CHIVAS VENTURE COMPETITION

Our portfolio company – Bioceltix – is among 5 startups that will compete for the victory in the grand finale of the national edition of the prestigious Chivas Venture competition.
The aim of the competition is to select and distinguish innovative startups that use their activities to solve social or environmental problems.

In the final round, which will take place on January 17 next year, the Jury will select one company that will represent Poland in the global final, competing with startups from 25 countries. The prize pool to be won in the competition is one million dollars.

Bioceltix changes the world! The company is the first in Europe to implement a safe animal-friendly and scalable business technology for the therapeutic use of allogeneic stem cells in a single donor – many recipients system.

Congratulations to the team and we keep our fingers crossed for victory!

APS WILL PROTECT AIRPORTS IN NORWAY AGAINST AERIAL THREATS

Our portfolio company Advanced Protection Systems (APS) announced a few days ago that its CTRL+SKY system will be used in Norway to protect airports from aerial threats.
The company signed a contract with AVINOR for the protection of the Stavanger airport, among others in the field of bird monitoring as well as detection and neutralization of drones.

Airports and surrounding areas are particularly vulnerable to intrusions of drones. Thanks to the multi-sensor design, the Ctrl+Sky system enables efficient detection and neutralization of drones both day and night, in 24/7 mode, in all weather conditions. The system guarantees the so-called “umbrella protection” without dead zones, which means that every flying intruder will be captured, and thus its neutralization will be possible.

Congratulations to the entire APS team for the next international cooperation and implementation!

NESTMEDIC WITH FOREIGN CONTRACTS. PREGNABIT GOES TO CONQUER FINLAND AND NIGERIA

Recent weeks have brought good news from Nestmedic – our portfolio company. The company continues the commercialization of the Pregnabit telemedical CTG solution for fetal health monitoring.
A few days ago, a distribution agreement was signed with the Nigerian company Health Cross Global Medical Solutions Limited. The contract concerns the distribution of the Pregnabit system in Nigeria, one of the world leaders in terms of fertility rate. As a result of the contract, only next year, about 295 devices for CTG testing at home will be brought to the Nigerian market.
This is the second agreement signed by Nestmedic with a foreign partner in the last few weeks. In the beginning of November, the Company announced that it had signed a cooperation agreement with a Finnish distributor, Steripolar Oy. The contract defines the commercial conditions of the distribution of the Pregnabit system in Finland.
(…) We are very pleased that we cooperate with a partner who has over 30 years of experience in the distribution of medical equipment, which gives us the opportunity to effectively commercialize our system on the Finnish market” – says Patrycja Wizińska-Socha, President of Nestmedic.
We congratulate the Nestmedic team on their success in foreign expansion and we keep our fingers crossed for further dynamic development of the Company.

FORBES ABOUT POLISH GUTENBERG – FILIP GRANEK – FOUNDER AND CEO OF XTPL

In the latest edition of the Forbes monthly, there is an article about the extraordinary path that Filip Granek went through, from a scientist to an effective leader and entrepreneur, awarded last week by EY in the Entrepreneur of the Year competition.
XTPL aspires to be a global company, the valuation of which exceeds one billion zlotys. However, it would not be a success without the vision and courage that Konrad Pankiewicz,  the first investor of XTPL, did not lack.
“(…) I invested in a project called “the world’s thinnest electrically conductive lines”, and when asked the author of the project, if he would be able to implement it, he replied with childish honesty that he had no idea. It was a matter of imagination and courage. I am glad that we did not miss it”– says Konrad Pankiewicz.
The entire article is available in the paper version of the latest issue of the Polish edition of FORBES magazine (12/2018). An excerpt of the article can be found here.
Photo: Bartek Sadowski/Forbes

FILIP GRANEK – CEO of XTPL, ENTREPRENEUR OF THE YEAR 2018 IN THE EY COMPETITION

Great news came from the Gala of the 16th edition of the EY Entrepreneur of the Year competition, which took place on November 22 in Warsaw. Filip Granek, founder and CEO of XTPL, our portfolio company, collected the statuettes in two categories. The first and at the same time the most important one is the Entrepreneur of the Year 2018, which the jury awarded for “work on a breakthrough technology that has a serious chance to change the world for the better”. This title entitles to represent Poland during the international final of the EY World Entrepreneur of the Year 2019 competition, which will be decided in June next year in Monaco.
The second category in which the CEO of XTPL won was the “New Business”, in which the jury awarded Filip Granek “for using his own scientific experience to create an innovative product on a global scale”.
Congratulations to Filip and we keep our fingers crossed for further success of XTPL!
More information here.

BACTERIA COMING OUT FROM THE SHADOW – PULS BIZNESU ABOUT BIOAVLEE

We have recently informed about the acquisition of another investor by our portfolio company Bioavlee. The funds obtained allow further development of the technology of identification of microorganisms.
“We set a new quality for laboratory equipment, making detection and identification of microorganisms faster, cheaper, simpler and more accurate” – says Michał Wronecki, CEO of Bioavlee.
What really are the groundbreaking solutions that Bioavlee develops and commercializes? You will find the answer to this question in the weekend edition of Puls Biznesu. We invite you to read!

BIOCELTIX AMONG THE FINALISTS OF THE CHIVAS VENTURE COMPETITION

Bioceltix is among the 11 finalists of the 4th edition of the Chivas Venture startup competition.
The aim of the competition is to select and distinguish innovative startups that use their activities to solve social or environmental problems.
In the beginning of December, after completing a series of workshops, five companies will be selected, which on January 17, 2019 will compete for the victory in the Grand Final of the national edition of the competition. During this event, the Jury will select one company that will represent Poland in the global final, competing with startups from 25 countries. The prize pool to be won is one million dollars.
Congratulations to the Bioceltix team and we keep our fingers crossed for winning!
More information at MamStartupl.pl.

APS AWARDED WITH THE INNOVATION LAUREL

Our portfolio company – Advanced Protection Systems – has been awarded the Innovation Laurel as part of the eighth edition of the “Stanisław Staszic Laurel of Innovation” competition.

The Competition Jury awarded APS the Bronze Laurel in the category “Construction and public utilities, security and firefighting”, for the creation of a multi-sensor system for the detection and neutralization of drones.
The “Laurel of Innovation” competition, organized by the Supreme Technical Organization (NOT), aims to promote innovative products, technologies and services, as well as all other modern solutions that can contribute to the accelerated social and economic development of Poland.

This is another distinction for APS solutions. Congratulations!
https://www.automatyka.pl/wiadomosci-i-komunikaty/laury-innowacyjnosci-im-stanislawa-staszica-rozdane–142439-10

APS AND GENOMTEC NOMINATED FOR THE ECONOMIC PRIZE OF THE PRESIDENT OF POLAND

21 enterprises have been nominated for the Award of the President of the Republic of Poland (XVI edition), which is an economic award granted once a year by the President of the Republic of Poland.
The President of the Republic of Poland Andrzej Duda will announce the winners in seven categories on November 15 during “Congress 590” in Rzeszów. This year, among the nominees, there were two companies from the Leonarto portfolio: Genomtec S.A. – in the category “Startup_PL” and Advanced Protection Systems S.A. – in the “Research+Development” category.
Our companies have been submitted for the Award by the Association of Stock Exchange Issuers (Genomtec) and the National Center for Research and Development (APS).

Congratulations for the nominees and we keep our fingers crossed for APS and Genomtec!
Chapter of the XVI edition of the Economic Award of the President of the Republic of Poland, source: www. prezydent.pl

GENOMTEC IN TOP 5 OF INCREDIBLES ACCELERATOR

We are pleased to inform you that our portfolio company Genomtec was among the five startups qualified for the finals of the second edition of the InCredibles accelerator, founded by Sebastian Kulczyk.

In this year’s event the organizers looked for companies that have a prototype of a new product or service, a proven team and are ready for international expansion.
The finalists of the competition will receive non-returnable grants of USD 50,000 and go through a mentoring program adapted to their needs. The winning teams will soon spend six weeks in the Silicon Valley, where they will meet, among others, with experts from Singularity University.

Over 300 teams from 34 countries have applied for participation in the second edition of InCredibles. These were startups mainly from Central and Eastern Europe, operating in the software, healthtech and fintech sectors.

Congratulations to the Genomtec team!
More information at MamStartup.pl.

PREGNABIT AWARDED AT PITCHFIRE COMPETITION 2018 IN DENMAR

Nestmedic’s telemedical CTG Pregnabit was awarded at the “Pitchfire Competition”, organized during the “Week of Health and Innovation” trade fair held on October 9-11 in Odense, Denmark.

The jury of the competition, after listening to many presentations of medical startups, rewarded the Nestmedic team for the Pregnabit telemedical CTG solution. Pregnabit is the world’s first comprehensive telemedicine solution for studying fetal well-being. The main element of the solution is a portable measuring device that allows for safe and reliable examination of the fetal heart rate, the mother’s pulse and the record of the uterine muscle contraction. The data collected by the device is transmitted wirelessly to the Medical Telemonitoring Center, operated by qualified medical personnel.

The Pitchfire Competition jury consisted of representatives of Venture Capital foundations, CONNECT Denmark, The Danish Growth Fund, regional and international business angels, and invited private investors. The prize in the competition is a dedicated business session with the best advisors in Denmark, gathered in the CONNECT Denmark organization.

Congratulations!

GENOMTEC WINS AT HUBWEEK IN BOSTON

Genomtec’s collection of awards is expanding. A few days ago, the company won the first place in the competition for the best startup from outside the US, organized during HUBweek in Boston.
This is one of the largest events in the technology industry on the East Coast of the United States, in which over 50,000 people representing dozens of industries and countries take part.

The Genomtec team had the opportunity to present their solution during HUBweek as a laureate of the 4th edition of MIT Enterprise Forum Poland – one of the largest acceleration programs for technological startups in Poland.

Genomtec has developed a portable device that allows diagnostics, among others of bacterial and viral infections, fungal infections or genetic mutations in any place within just 20 minutes, without having to prepare a sample of biological material. The Genomtec team also developed a device dedicated to the fruit and vegetable market. “Genomtec Fresh” analyzes the microbiological composition of soil, plants and water. It enables fast and cheap diagnostics of viruses and bacteria, and thus contributes to the increase of harvest and allows to minimize the use of chemicals.

Congratulations to the entire Genomtec team!

QUARTICON POTENTIAL RECOGNIZED BY A FOREIGN INVESTOR

QuarticON, our portfolio company, which created the systems of support and personalization of sales processes and Internet marketing based on artificial intelligence, raised PLN 8 million from the German Acatis Investment fund.

“We have seen that QuarticOn is well on its way to effectively use technology based on artificial intelligence to support sales in online stores, improving their competitiveness. The company has been steadily increasing its revenues and customer base, so it was natural for us to financially support its further development” – said Dr. Hendrik Leber, Managing Partner at Acatis Investment GmbH.

The funds obtained from Acatic Investment will be used by the Company for expansion into new markets and completion of work on a solution in the SaaS model.
QuarticON wants to debut on New Connect stock exchange in October.
We keep our fingers crossed for a successful debut!

More information in Puls Biznesu.

INNOVATIONS IN THE FINTECH INDUSTRY. MEET FUNEDA – OUR NEXT INVESTMENT

Funeda is an innovative company from the consumer financial services sector. The company develops an advanced creditworthiness and fraud risk assessment engine based on the Big Data methods and self-learning algorithms. The technology based on machine learning makes algorithms evolve and calibrate parameters in real time. The unique feature of the engine is the possibility of its application in various markets. Funeda started operations on the Polish FinTech market in April this year, while in Q42018 it plans to start operations on the first foreign market, with a potential much higher than the Polish market.

Leonarto Alfa investment is co-financed by the European Union from the European Regional Development Fund under the Operational Program Smart Development, Sub-measure 1.3.1. Support for research and development projects in the preseed phase by proof of concept funds – BRIdge Alfa.

Contact us